IL6 and head and neck squamous cell carcinoma: It demonstrates that Fb-induced IL-6/IL-6R activation drives the MAPK/ERK pathway in both HPV-negative and HPV-positive cells, promoting EMT and enhancing radioresistance, while the classical IL-6/IL-6R/STAT axis plays a role only in HPV-negative HNSCC.